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Muscarinic receptor types and their effects on the inositol phosphate second messenger system were studied 
in enzymatically dispersed rat gastric mucosal cells. Radioreceptor binding studies indicated the presence 
of a single class of binding sites (4860 + 875 sites/cell) and affinities of 0.42 If: 0.12 nM, 176 + 32 nM 
and 13 PM for N-methylscopolamine, pirenzepine and carbachol, respectively. In cells prelabelled with myo- 
[3H]inositol carbachol induced a dose-dependent increase in inositol-l-phosphate in the presence of lithium 
with an ED,, of 10 PM which was antagonized by atropine and pirenzepine (IC,, 9 and 700 nM, respective- 
ly). Carbachol stimulated amino[‘4C]pyrine uptake, used as a measure of acid secretion, with an ED,, of 
10 PM. The good correlation between these responses uggests a role for inositol phosphates in the musca- 
rinic MZ-receptor mediated acid secretion. 
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1. INTRODUCTION 
The interactions of histamine and acetylcholine 
with their surface receptors on gastric mucosal 
parietal cells initiate the secretion of hydrogen ions 
[1,2]. The response to histamine occurs through 
receptor-mediated stimulation of cyclic adenosine 
monophosphate (CAMP). The second messenger 
of muscarinic cholinergic receptors has, until pre- 
sent, remained elusive. Available data indicate that 
the enzymes adenylate or guanylate cyclase are not 
involved [l-3]. The acid secretory response to 
cholinergic agonists was highly susceptible to 
changes in extracellular calcium concentration 
[1,2] thereby resembling the calcium dependence 
of some cholinergic receptors in other tissues 
which are known to enhance the turnover rates of 
phosphatidylinositols [4]. Recent work suggests 
that the increased turnover of phosphatidylino- 
sitols is secondary to a receptor-mediated activa- 
tion of a polyphosphoinositol phosphodiesterase 
which cleaves the phospholipid into inositol 
phosphates and 1 ,Zdiacylglycerol [4]. Inositol- 
1,4,5-trisphosphate appears to release calcium 
from nonmitochondrial intracellular stores [4], 
while 1,2-diacylglycerol activates the calcium- and 
phospholipiddependent protein kinase C [5]. 
These mechanisms are likely to represent an impor- 
tant second messenger system involved in calcium- 
dependent signal transmission. 
Recent evidence suggests that muscarinic recep- 
tors are not homogeneous [6-S]. A subclassifica- 
tion has been proposed based primarily on phar- 
macologic studies with the muscarinic antagonist 
pirenzepine [7]. The Ml-receptors display a high 
affinity for pirenzepine while MZreceptors bind 
pirenzepine with an approx. 40-200-fold lower af- 
finity [6,8-lo]. To characterize the type of 
muscarinic receptor present in rat gastric mucosal 
cells we performed radioreceptor binding studies 
with muscarinic antagonists and an agonist. We 
then investigated whether gastric mucosal 
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muscarinic receptors are coupled to the 
phosphoinositol second messenger system. Finally, 
stimulation of aminopyrine uptake (as a measure 
of hydrogen ion secretory response) by the 
muscarinic agonist carbachol was employed to 
assess a cellular response to receptor activation. 
Our results suggest hat muscarinic receptors in rat 
gastric mucosal cells display a low affinity for 
pirenzepine (MZreceptors) and stimulate acid 
secretion by increasing intracellular concentrations 
of inositol phosphates. 
2. MATERIALS AND METHODS 
Rat gastric mucosal cells were isolated as 
described [11,12]. After isolation cells were washed 
in buffer C (composition in mM: 70 NaCl, 5 KCl, 
1.5 sodium phosphate, 50 Hepes, 20 sodium bicar- 
bonate, 1 .O calcium, 1.5 magnesium, 0.2% bovine 
serum albumin). Cell viability was greater than 
90% as estimated by the trypan blue exclusion test. 
2.1. Binding studies 
The cells were diluted to 2 x lo6 cells/ml and in- 
cubations with tritiated N-methylscopolamine 
(NMS) and drugs were performed in 1 ml buffer C 
for 20 min at 37°C. Incubations were terminated 
by rapid filtration through Whatman GFC glass 
fiber filters under reduced pressure. The filters 
were washed with 2 x 3 ml buffer C and radioac- 
tivity retained was determined. Specific binding, 
calculated by subtraction of binding in the 
presence of 0.1 PM NMS was 60-80% of the total 
radioactivity retained on the filters. 
2.2. Phosphoinositol experiments 
The isolated cells were incubated at 10’ cells/ml 
with 10 &i/ml of tritiated myo-inositol 
(17 Ci/mmol) in oxygenated buffer C for 2 h and 
washed 3 times in buffer C supplemented with 
0.1 mM unlabeled myo-inositol. After final 
resuspension in buffer C incubations were per- 
formed in 0.4 ml and terminated by adding 1 ml of 
ice-cold methanol. The phosphoinositol assays 
were performed as described in [13]. Lipids were 
extracted by addition of 0.5 ml chloroform and 
vortex-mixing for 10 s. Another 0.5 ml 
chloroform and 0.5 ml water were added and the 
tubes were centrifuged. The upper phase was ap- 
plied to 1 ml columns of Dowex l-X8 in the for- 
mate form (Bio Rad) and washed with 10 ml water 
and 15 ml of 60 mM sodium formate/ mM 
sodium tetraborate. Inositol-l-phosphate (IP) was 
eluted with 15 ml of 0.2 M ammonium for- 
mate/O.1 M formic acid. Radioactivity was deter- 
mined in the first 5 ml of each eluate by liquid scin- 
tillation spectrophotometry. The elution of IP was 
controlled with a 14C-labelled standard. 
The accumulation of IP varied between 2- and 
6-fold basal levels during 30 min in 10 individual 
experiments. Parietal cells accumulated 3-6-times 
more IP than the smaller and metabolically [1,2] 
less active nonparietal cells when compared by cell 
number. For these experiments parietal cells were 
enriched to a content of 70-90% by isopycnic cen- 
trifugation in percoll [ 111. 
2.3. Aminopyrine uptake 
The accumulation of amino[14C]pyrine as 
described by Sonnenberg et al. [l l] and modified 
by Ecknauer et al. [14] was used as an indirect 
measure of hydrogen ion production. Incubations 
(l-2 x lo6 cells/ml in buffer C) performed in the 
presence of 10 pM dibutyryl-CAMP [14] were ter- 
minated by adding 0.4 ml of the cell suspension to 
1 ml cold buffer C and centrifugation for 1 min. 
The supernatant was removed, the pellet washed 
once with 1 ml cold buffer C and then dissolved in 
100 ~1 of 1 M NaOH for determination of radioac- 
tivity. The maximal stimulation of aminopyrine 
accumulation varied between 2- and IO-fold in in- 
dividual experiments without affecting dose 
response relations. 
2.4. Statistical methods 
Data are reported as means f SE from triplicate 
determinations from representative xperiments. 
All experiments were repeated at least twice with 
reproducible results. EDSO and ICSO values were 
determined by the log-probit method. 
2.5. Materials 
Reagents were of analytical grade and were pur- 
chased from Merck, Darmstadt, unless indicated 
otherwise. Hepes (Serva, Heidelberg), bovine 
serum albumin and NMS (Sigma, Taufkirchen, 
FRG), tritiated N-methylscopolamine, myo- 
inositol, amino[‘4C]pyrine and [14C]IP (Amer- 
sham Buchler, Dreieich, FRG). 
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3. RESULTS 
The interaction of carbachol and of the 
muscarinic antagonist pirenzepine with muscarinic 
receptors was investigated by heterologous com- 
petition studies in which tritiated N- 
methylscopolamine was displaced by the respective 
unlabeled ligand. The data were analysed by use of 
the computerized nonlinear least squares curve fit- 
ting program ‘Ligand’ [15] to derive kinetic 
parameters from equilibrium binding studies 
(fig.1). The binding capacity was 4850 f 875 
sites/cell. The data were best represented by a 
model assuming a single binding site to which 
NMS had an affinity of Kd = 0.43 f 0.12 nM, 
pirenzepine Kd = 176 f 32 nM. The, goodness-of- 
fit was not improved by fitting the data to a two- 
binding site model. Carbachol displayed an affini- 
ty of Kd = 12.8 f 5.5~M to 63% and an affinity 
of Kd = 1.4 f 0.9 mM to 37% of the binding sites. 
The two-site model fitted the data significantly bet- 
ter than a l-site model (p = 0.01). 
The effect of the muscarinic agonist carbachol 
on the release of inositol phosphates was in- 
vestigated in isolated cells prelabeled with tritiated 
inositol for 2 h. The subsequent addition of 
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Fig. 1. Displacement of tritiated NMS by unlabeled 
NMS, pirenzepine and carbachol in isolated rat gastric 
mucosal cells. The concentration of fl(H)NMS was 
0.25 nM. The curves for NMS and pirenzepine were best 
fitted to models assuming a single binding site. The 
displacement curve of carbachol was significantly better 
fitted by a model assuming 2 binding sites (data from 3 
experiments, D.F.28, F = 40.3). The affinities are stated 
in the text. 
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Fig.2. Time course of inositol phosphate accumulation 
stimulated by 0.1 mM carbachol in is&ted gastric 
mucosal ceils in the presence or absence of 10 mM LiCl. 
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Fig.3. Effect of carbachol on the accumulation of 
inositol phosphates during 30 min in isolated rat gastric 
mucosal cells. 
0.1 mM carbachol caused a time-dependent in- 
crease in IP in the presence of 10 mM LiCl (fig.2) 
a known inhibitor of IP phosphatase [17] which 
was used to amplify the response. The maximal in- 
crease in IP varied between 2- and 4-fold of control 
levels in 10 independent experiments. The increase 
in IP was blocked in the presence of 1 PM atropine 
(fig.2). In a dose-response study, half-maximal 
stimulation of IP was observed in the presence of 
12 f 4/rM carbachol (fig.3). In further ex- 
periments the potencies of atropine and 
pirenzepine to inhibit the inositol phosphate 
response tog 0.1 mM carbachol were evaluated. 
Half-maximal inhibition was observed in the 
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presence of 9 j, 3 nM atropine or 700 f 200 nM 
pirenzepine (fig.4). 
The accumulation of amino[ ‘“C]pyrine was used 
to obtain an index of acid secretion by parietal cells 
in response to carbachol. The ~ino[“C]p~ne 
accumulation proved to be rather small when car- 
bachol was added as the only stimulant. Ecknauer 
et al. [14] reported that larger striation was ob- 
tained when carbachol was added in the presence 
of dibutyryi-cAMP which enhanced the secretory 
response to carbachol without affecting dose- 
lo-'0 10-9 MKOR :i-i’ 10-6 lo- 9 1o-L 
Fig.4. Inhibition of inositol phosphate ac~um~atioR in 
response to carbachol (O-1 mM) by the muscarinic 
antagonists atropine or pirenzepine. It should be noted 
that the inhibition curves were carried out in the 
presence of 0.1 mM carbachol and hence ICSO values will 
be greater than & values. 
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Fig.5 Accumulation of amino[i4C]pyrine in response to 
carbachol in the presence of 0.01 mM dibutyryl-CAMP. 
response relations [14]. We therefore adopted this 
method which exploits the synergism between 
CAMP- and inositol phosphate-dependent acid 
secretion. Dibutyryl-cAMP (10 pM) enhanced 
~uo[“C]py~ne a~cum~ation by 100%. Car- 
bachol caused afurther dose-dependent accumula- 
tion and half-maximal stimulation was observed at 
8 f 4,uM carbachol (n = 3) (fig.5). 
4. DISCUSSION 
The present study correlates muscariuic receptor 
binding to the stimulation of inositol phosphate 
formation and acid secretion i  rat gastric mucosal 
cells. The muscarinic antagonist NMS labeled a 
single apparent pop~ation of, binding sites with 
high affinity in agreement with previous data ob- 
tained with this ligand [8,9]. In contrast o other 
muscarinic antagonists pirenzepirre interacts with 
different populations of muscarinic binding sites 
with affinities ranging from 40 to 3000 nM [6-lo]. 
This has permitted a ~stin~ion of muscari.nic 
receptors to which pirenzepine displays a high af- 
finity, termed Ml-sites, from such to ‘which 
pirenzepine displays a low affinity, termed 
M2-sites. In rat gastric mucosal cells pirenzepine 
bound to a single population of binding sites with 
an affinity of 0.2&M which agrees with the 
presence of M2-sites. Similar results have been 
described by Hammer [lo] in homogenates ofi 
canine gastric mucosal membranes. The affinity 
(&) of carbachol of 13 pM a&o agrees with 
previous data obtained in rat gastric mucosa [14]. 
The interaction of rn~sc~nic agonists with dif- 
ferent affinity states of the muscarinic receptors i
a well-known phenomenon [6-10,181. Our results 
suggest that the higher-affi~ty state of the recep- 
tor is involved in mediating muscarinic responses, 
Carbachol stimulated the release of inositol 
phosphates as indicated by the tie-dependent ac- 
cumulation of IP in the presence of lithium. The 
inhibition of inositol-1-phosphatase by lithium 
113) led to an accumulation of IP over time. This 
product probably derived from the degradation of
inositol triphosphate to inositol diphosphate and 
IP as indicated by previous studies 14, I3]. Half- 
maximal stimulation of IP was observed in the 
presence of 10pM carbachol which represents a 
concentration very close to the one required for 
half-maximal occupation of muscarinic receptors 
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and therefore suggests the absence of spare 
receptors. 
Parietal cells accounted for more than 50% of 
the IP accumulated although they represented only 
approx. 20% of the cell population. This may 
reflect the greater cell volume or the greater 
responsiveness of parietal cells to carbachol. Fur- 
ther studies are needed to investigate this point. 
A comparison of the inhibitory potencies of 
atropine and pirenzepine in a given experimental 
system may be used as an additional parameter to 
distinguish Ml- from MZreceptors [6,9,10,16]. 
Pirenzepine was about 5-fold less potent than 
atropine at Ml-receptors in inhibiting muscarinic 
responses while lOO-200-fold lower affinities were 
observed for the MZ-receptors [la]. Thus, the 
relatively low potency of pirenzepine in inhibiting 
the muscarinic response suggests that MZreceptors 
are involved in inositol phosphate generation in rat 
gastric mucosal cells. Similar results have been 
reported by Rosenfeld [17] who compared the in- 
hibition of carbachol-stimulated aminopyrine ac- 
cumulation by pirenzepine and atropine in rat 
mucosal cells. 
Our data contrast with the previously made pro- 
posal that MZ-receptors are involved in the inhibi- 
tion of adenylate cyclase while Ml-receptors 
mediate the inositol phosphate response [18]. Our 
observations agree, however, with a recent study 
[9] which indicated that MZreceptors in chick 
heart cells mediate inositol phosphate release while 
Ml-receptors are coupled to the inhibition of 
adenylate cyclase. 
In agreement with previous studies in isolated 
rat gastric cells 114,171 carbachol stimulated acid 
secretion half-maximally at a concentration of 
10,uM. The dose response for acid secretion thus 
closely paralleled the response for inositol 
phosphate generation. Our data therefore support 
the view that muscarinic receptors on rat parietal 
cells stimulate acid secretion by activating a 
phospholipase C-type phosphodiesterase which 
results in the release of phosphoinositols. 
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